Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Prasugrel to Ticagrelor (SWAP-3)
NCT02016170Phase 4Completed
- Sponsor
- University of Florida
- Start
- Mar 2014
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), acute coronary syndrome (ACS), sponsored by University of Florida. Started Mar 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02016170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016170.